To require an annual report on anti-retroviral drug procurement.

SA 1253. Mr. FEINGOLD submitted an amendment intended to be proposed by him to the bill H.R. 3057, making appropriations for foreign operations, export financing, and related programs for the fiscal year ending September 30, 2006, and for other purposes; which was ordered to lie on the table; as follows:

On page 326, between lines 10 and 11, insert the following:

REPORT ON ANTI-RETROVIRAL DRUG PROCUREMENT

Sec. 6113. (a) Not later than 90 days after the date of enactment of this Act, the Coordinator of United States Government Activities to Combat HIV/AIDS Globally shall make available to the public a report setting forth the amount of United States funding provided under the authorities of the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003 (22 U.S.C. 7601 et seq.), or under an amendment made to that Act, to procure anti-retroviral drugs in a country described in section 1(f)(2)(B)(VII) of the State Department Basic Authorities Act of 1956 (22 U.S.C. 2651a(f)(2)(B)(VII)). The report shall include a detailed description of the anti-retroviral drugs procured, including--

(1) the amount expended for generic and for name brand anti-retroviral drugs;

(2) the price paid per unit of each such drug; and

(3) the vendor from which such drugs were purchased.

(b) Not later than January 31 of each year, the Coordinator of United States Government Activities to Combat HIV/AIDS Globally shall update the report required by subsection (a) and make such updates available to the public.